Sharda Cropchem Limited (NSE:SHARDACROP)
India · Delayed Price · Currency is INR 712.75
+22.25 (3.22%)
Nov 11, 2026, 1:44 PM IST
Sharda Cropchem Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 54,791 | 52,676 | 43,199 | 31,630 | 40,452 | 35,798 | |
Revenue Growth | 17.28% | 21.94% | 36.57% | -21.81% | 13.00% | 49.43% |
Cost of Revenue | 34,873 | 33,778 | 30,286 | 23,429 | 28,612 | 25,004 |
Gross Profit | 19,918 | 18,898 | 12,913 | 8,201 | 11,839 | 10,794 |
Selling, General & Admin | 1,072 | 990.02 | 796.63 | 587.8 | 553.35 | 488.89 |
Other Operating Expenses | 7,501 | 7,181 | 5,292 | 4,307 | 4,598 | 3,014 |
Operating Expenses | 12,282 | 11,416 | 8,836 | 7,566 | 7,632 | 5,956 |
Operating Income | 7,636 | 7,481 | 4,077 | 635.21 | 4,207 | 4,838 |
Interest Expense | -35.65 | -17.57 | -21.06 | -36.19 | -45.1 | -22.13 |
Interest & Investment Income | 187.32 | 187.32 | 63.07 | 45.4 | 49.03 | 64.54 |
Currency Exchange Gain (Loss) | -231.67 | 366.92 | -179 | -3.86 | - | -164.57 |
Other Non Operating Income (Expenses) | 713.22 | 549.35 | 349.07 | 339.28 | 174.65 | 12.61 |
EBT Excluding Unusual Items | 8,269 | 8,567 | 4,289 | 979.84 | 4,386 | 4,728 |
Impairment of Goodwill | - | - | - | - | - | -4.33 |
Gain (Loss) on Sale of Investments | 349.79 | 340.69 | 147.84 | 39.96 | 20.32 | 62.72 |
Gain (Loss) on Sale of Assets | 0.25 | 0.25 | 0.2 | - | 0.55 | - |
Asset Writedown | -374.56 | -374.56 | -680.83 | -348.64 | -119.41 | -292.31 |
Other Unusual Items | 21.24 | 21.24 | 26.86 | 47.56 | 20.37 | 148.35 |
Pretax Income | 8,266 | 8,555 | 3,783 | 718.72 | 4,307 | 4,642 |
Income Tax Expense | 1,830 | 1,745 | 739.21 | 399.65 | 887.62 | 1,150 |
Earnings From Continuing Operations | 6,436 | 6,810 | 3,044 | 319.06 | 3,420 | 3,493 |
Minority Interest in Earnings | 0.09 | -1.31 | -0.39 | -0.23 | -0.23 | -0.24 |
Net Income | 6,436 | 6,809 | 3,044 | 318.83 | 3,420 | 3,493 |
Net Income to Common | 6,436 | 6,809 | 3,044 | 318.83 | 3,420 | 3,493 |
Net Income Growth | 42.45% | 123.69% | 854.67% | -90.68% | -2.09% | 52.40% |
Shares Outstanding (Basic) | 90 | 90 | 90 | 90 | 90 | 90 |
Shares Outstanding (Diluted) | 90 | 90 | 90 | 90 | 90 | 90 |
Shares Change | 0.00% | - | - | - | - | - |
EPS (Basic) | 71.34 | 75.47 | 33.74 | 3.53 | 37.90 | 38.71 |
EPS (Diluted) | 71.34 | 75.47 | 33.74 | 3.53 | 37.90 | 38.71 |
EPS Growth | 42.44% | 123.69% | 854.67% | -90.68% | -2.09% | 52.40% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 6,146 | 6,551 | 6,035 | 3,408 | 3,276 | 2,668 |
Free Cash Flow Per Share | 68.13 | 72.62 | 66.89 | 37.78 | 36.31 | 29.57 |
Dividend Per Share | - | 15.000 | 9.000 | 3.000 | 6.000 | 6.000 |
Dividend Growth | - | 66.67% | 200.00% | -50.00% | 0% | 20.00% |
Gross Margin | 36.35% | 35.88% | 29.89% | 25.93% | 29.27% | 30.15% |
Operating Margin | 13.94% | 14.20% | 9.44% | 2.01% | 10.40% | 13.51% |
Profit Margin | 11.75% | 12.93% | 7.05% | 1.01% | 8.45% | 9.76% |
Free Cash Flow Margin | 11.22% | 12.44% | 13.97% | 10.78% | 8.10% | 7.45% |
EBITDA | 11,272 | 10,654 | 6,752 | 3,233 | 6,610 | 7,242 |
EBITDA Margin | 20.57% | 20.23% | 15.63% | 10.22% | 16.34% | 20.23% |
D&A For EBITDA | 3,636 | 3,172 | 2,675 | 2,598 | 2,403 | 2,405 |
EBIT | 7,636 | 7,481 | 4,077 | 635.21 | 4,207 | 4,838 |
EBIT Margin | 13.94% | 14.20% | 9.44% | 2.01% | 10.40% | 13.51% |
Effective Tax Rate | 22.14% | 20.40% | 19.54% | 55.61% | 20.61% | 24.76% |
Revenue as Reported | 56,386 | 54,098 | 43,794 | 32,228 | 40,854 | 36,086 |
Advertising Expenses | - | 278.75 | 244.19 | 134.24 | 78 | 24.05 |